Fig. 1From: Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern AfricaMap of the study site in Vhembe District, Limpopo Province, South Africa. The six primary health care clinics (H) and village catchment areas where participants were recruited are indicated. The study district in Limpopo Province is shown alongside other malaria-endemic provinces of KwaZulu-Natal and Mpumalanga, is in close proximity to Botswana, Zimbabwe and MozambiqueBack to article page